Skip to main content
Rachael Grace, MD, Pediatric Hematology & Oncology, Boston, MA, Dana-Farber Cancer Institute

RachaelGraceMD

Pediatric Hematology & Oncology Boston, MA

Associate Professor, Boston Children's Hospital

Dr. Grace is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Grace's full profile

Already have an account?

Education & Training

  • Childrens Hospital
    Childrens HospitalFellowship, Pediatric Hematology/Oncology, 2007 - 2010
  • Childrens Hospital
    Childrens HospitalResidency, Pediatrics, 2003 - 2006
  • The Warren Alpert Medical School of Brown University
    The Warren Alpert Medical School of Brown UniversityClass of 2003

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2006 - 2023
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • A Phase 3 Study of Eltrombopag Vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia in Children
    Rachael F. Grace, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Characterization of the Severe Phenotype of Pyruvate Kinase Deficiency
    Rachael F. Grace, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Comorbidities and Complications in Adults with Pyruvate Kinase Deficiency
    Rachael F. Grace, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • An Ongoing Global, Longitudinal, Observational Study of Patients with Pyruvate Kinase Deficiency: The PEAK Registry 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Special Education Session on ASH Clinical Practice Guidelines on Immune Thrombocytopenia 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Long-Term Safety and Efficacy of Mitapivat (AG-348), a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase Deficiency: The DRIVE PK Study 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Join now to see all

Press Mentions

  • Mitapivat Elicits Positive Response in Pyruvate Kinase Deficiency
    Mitapivat Elicits Positive Response in Pyruvate Kinase DeficiencySeptember 4th, 2019
  • Agios to Present Updated Clinical Data from PKR Activator AG-348 at EHA
    Agios to Present Updated Clinical Data from PKR Activator AG-348 at EHAMay 18th, 2017
  • More Than 110 Dana-Farber Affiliated Faculty Named as 2021 Top Doctors in Boston Magazine
    More Than 110 Dana-Farber Affiliated Faculty Named as 2021 Top Doctors in Boston MagazineJanuary 14th, 2021

Hospital Affiliations